Data gathered: July 30
AI Stock Analysis - Bioventus (BVS)
Analysis generated July 30, 2025. Powered by Chat GPT.
Bioventus Inc. is a global medical device company that delivers clinically proven, high-quality biological products that facilitate healing. Their mission is to offer a wide range of innovative products focused on enabling healing in orthobiologics, osteoarthritis, and surgical solutions. With a robust focus on innovation and customer-centric solutions, Bioventus aims to provide impactful medical solutions to patients worldwide.
Stock Alerts - Bioventus (BVS)
 |
Bioventus | July 22 Employee Rating is down by 2.6% over the last month. |
|
Bioventus | July 1 Price is up by 7.9% in the last 24h. |
|
Bioventus | June 11 Employee Rating is down by 7.3% over the last month. |
|
Bioventus | June 11 Business Outlook among employees is down by 13.8% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Bioventus
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 37 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 32 | Sign up | Sign up | Sign up |
| Patents | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 626 | Sign up | Sign up | Sign up |
| Instagram Followers | 712 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 422 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,850 | Sign up | Sign up | Sign up |
| Twitter Mentions | 5 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 25,500 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 74 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,124 | Sign up | Sign up | Sign up |
About Bioventus
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body’s natural healing process in the United States and internationally.
| Price | $6.54 |
| Target Price | Sign up |
| Volume | 996,660 |
| Market Cap | $436M |
| Year Range | $6.2 - $12.29 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Medical Devices |
In the news
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation ProductsJuly 30 - GlobeNewswire |
|
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025July 29 - GlobeNewswire |
|
 |
Stephens Inc. AR Lowers Stock Position in Bioventus Inc. (NYSE:BVS)July 21 - ETF Daily News |
 |
Bioventus (NASDAQ:BVS) Stock Rating Lowered by Wall Street ZenJuly 20 - ETF Daily News |
 |
Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight RatingJuly 16 - Yahoo Entertainment |
 |
With 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interestJuly 9 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 124M | 41M | 83M | -2.6M | 16M | -0.040 |
| Q4 '24 | 154M | 51M | 101M | -160,000 | 22M | 0.150 |
| Q3 '24 | 139M | 45M | 94M | -4.8M | 17M | 0.060 |
| Q2 '24 | 151M | 48M | 104M | -24M | -16M | 0.190 |
| Q1 '24 | 129M | 41M | 88M | -4.6M | 17M | 0.070 |
Insider Transactions View All
| CHURCH KATRINA J filed to sell 55,557 shares at $7.6. April 15 '25 |
| D'Adamio Anthony filed to sell 131,416 shares at $7.6. April 15 '25 |
| Singleton Mark Leonard filed to sell 141,088 shares at $7.6. April 15 '25 |
| Singleton Mark Leonard filed to sell 131,963 shares at $9.8. March 25 '25 |
| D'Adamio Anthony filed to sell 124,449 shares at $9.8. March 18 '25 |
Similar companies
Read more about Bioventus (BVS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bioventus?
The Market Cap of Bioventus is $436M.
What is the current stock price of Bioventus?
Currently, the price of one share of Bioventus stock is $6.54.
How can I analyze the BVS stock price chart for investment decisions?
The BVS stock price chart above provides a comprehensive visual representation of Bioventus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bioventus shares. Our platform offers an up-to-date BVS stock price chart, along with technical data analysis and alternative data insights.
Does BVS offer dividends to its shareholders?
As of our latest update, Bioventus (BVS) does not offer dividends to its shareholders. Investors interested in Bioventus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bioventus?
Some of the similar stocks of Bioventus are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.